Author: Derosa Giuseppe
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.11, Iss.6, 2011-12, pp. : 357-362
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pioglitazone/rosiglitazone: Liver failure: 17 case reports
Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. :
Similar CV risks observed with rosiglitazone and pioglitazone
Reactions Weekly, Vol. 1, Iss. 1318, 2010-01 ,pp. :
Pioglitazone/rosiglitazone: Graves' ophthalmopathy: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1331, 2010-01 ,pp. :
Pioglitazone, rosiglitazone face up to MI, HF risk analyses
Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. :
Pioglitazone/rosiglitazone: First report of leucopenia and thrombocytopenia: case report
Reactions Weekly, Vol. 1, Iss. 1086, 2006-01 ,pp. :